**
A recent analysis has revealed that an overwhelming majority of NHS trusts in England are failing to meet established cancer treatment targets, with some patients facing waits of over 104 days before receiving critical care. The figures highlight a troubling trend, raising concerns over the quality and timeliness of cancer treatment within the National Health Service (NHS).
Disparities in Cancer Treatment Access
The NHS has long maintained a benchmark requiring that at least 85% of cancer patients begin treatment within 62 days of an urgent referral. Unfortunately, this target has not been achieved since 2014, and new data indicates that only three out of 119 acute trusts managed to meet or surpass this goal last year. Alarmingly, some of the worst-performing trusts only managed to treat approximately half of their patients in the required timeframe.
In 2025, the trusts that met the 85% target were Calderdale and Huddersfield, with 89.2% of patients treated within the timeframe, followed closely by Homerton Healthcare at 85.8% and Maidstone & Tunbridge Wells at 85.7%. In stark contrast, trusts such as Mid & South Essex, Sheffield Teaching Hospitals, and Hull University Teaching Hospitals treated fewer than 55% of their patients within 62 days.
The overall statistics reveal that just 69.1% of patients across England began cancer treatment within the required timeframe, a marginal improvement from 67.7% in 2024 but still far below the national target.
Government Response and Interim Goals
In light of these concerning statistics, the UK Government has set an interim target of achieving 75% of patients commencing treatment within 62 days by March 2026. Michelle Mitchell, Chief Executive of Cancer Research UK, expressed her deep concern, stating, “Every cancer patient deserves access to timely, high-quality care. Although NHS staff are working hard, far too many people still face unacceptable delays for vital treatment.”
Mitchell emphasised the need for enhanced investment in the NHS workforce and equipment to facilitate real change in patient care. The analysis underscores a pressing need for reforms, as 65 of the 119 trusts reported an increase in the percentage of patients seen within 62 days, while 54 experienced a decline.
The Human Cost of Delayed Treatment
The pressure on cancer services is further illustrated by data indicating that in some trusts, as many as one in seven patients began treatment after waiting more than 104 days following an urgent referral. For example, University Hospitals of Leicester reported that 13.7% of patients experienced this lengthy wait. The situation was similarly dire at Guy’s and St Thomas’, where 15.5% of patients faced delays exceeding 104 days.
The impact of these delays is profound. Patients awaiting treatment are not only left in a state of uncertainty regarding their health but may also experience a deterioration in their condition, potentially complicating treatment outcomes.
Improving Cancer Care: A Call to Action
Amidst the challenges, NHS trusts are taking steps to address these issues. Leaders from various trusts, including Sheffield Teaching Hospitals and Hull University Teaching Hospitals, have outlined plans to expand diagnostic capacity and reduce waiting times through additional clinics and enhanced scheduling.
Dawn Scrafield, Chief Executive of Mid & South Essex NHS Foundation Trust, highlighted the trust’s commitment to improving cancer care, stating, “We know we need to do more, and that our patients deserve better. We have invested in new technologies to help us treat cancer more quickly.”
While these efforts show promise, the path to improving cancer treatment in the NHS remains fraught with obstacles, including staffing shortages and outdated equipment.
Why it Matters
The findings of this analysis are not merely statistics; they represent real people and families grappling with the fears and uncertainties that come with a cancer diagnosis. The persistent delays in treatment are a call to action for both the government and healthcare leaders to prioritise cancer care. Ensuring timely access to treatment is critical not only for patient survival but also for enhancing the overall effectiveness of the healthcare system. As the NHS strives to meet its targets, it is vital that it secures the resources and support needed to provide every cancer patient with the timely, high-quality care they deserve.
